Morphometric, Hemodynamic, and Biomechanical Factors Influencing Blood Flow and Oxygen Concentration in the Human Lamina Cribrosa.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
09 04 2020
Historique:
entrez: 10 4 2020
pubmed: 10 4 2020
medline: 22 8 2020
Statut: ppublish

Résumé

We developed a combined biomechanical and hemodynamic model of the human eye to estimate blood flow and oxygen concentration within the lamina cribrosa (LC) and rank the factors that influence LC oxygen concentration. We generated 5000 finite-element eye models with detailed microcapillary networks of the LC and computed the oxygen concentration of the lamina retinal ganglion cell axons. For each model, we varied the intraocular pressure (IOP) from 10 mm Hg to 55 mm Hg in 5-mm Hg increments, the cerebrospinal fluid pressure (13 ± 2 mm Hg), cup depth (0.2 ± 0.1 mm), scleral stiffness (±20% of the mean values), LC stiffness (0.41 ± 0.2 MPa), LC radius (1.2 ± 0.12 mm), average LC pore size (5400 ± 2400 µm2), the microcapillary arrangement (radial, isotropic, or circumferential), and perfusion pressure (50 ± 9 mm Hg). Blood flow was assumed to originate from the LC periphery and drain via the central retinal vein. Finally, we performed linear regressions to rank the influence of each factor on the LC tissue oxygen concentration. LC radius and perfusion pressure were the most important factors in influencing the oxygen concentration of the LC. IOP was another important parameter, and eyes with higher IOP had higher compressive strain and slightly lower oxygen concentration. In general, superior-inferior regions of the LC had significantly lower oxygen concentration than the nasal-temporal regions, resulting in an hourglass pattern of oxygen deficiency. To the best of our knowledge, this study is the first to implement a comprehensive hemodynamical model of the eye that accounts for the biomechanical forces and morphological parameters of the LC. The results provide further insight into the possible relationship of biomechanical and vascular pathways leading to ischemia-induced optic neuropathy.

Identifiants

pubmed: 32271886
pii: 2764407
doi: 10.1167/iovs.61.4.3
pmc: PMC7401712
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3

Références

Invest Ophthalmol Vis Sci. 1991 Feb;32(2):401-5
pubmed: 1993592
PLoS One. 2014 Dec 22;9(12):e114935
pubmed: 25531761
Ann Biomed Eng. 2004 Nov;32(11):1519-29
pubmed: 15636112
Ophthalmology. 2005 Feb;112(2):245-50
pubmed: 15691558
Appl Opt. 2018 Jun 10;57(17):4865-4871
pubmed: 30118104
Br J Ophthalmol. 2003 Aug;87(8):949-51
pubmed: 12881331
Invest Ophthalmol Vis Sci. 2017 Apr 1;58(4):2044-2053
pubmed: 28384725
J Biomed Opt. 2007 Mar-Apr;12(2):024029
pubmed: 17477744
Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6167-6179
pubmed: 27842158
Microcirculation. 2002 Jul;9(3):189-96
pubmed: 12080416
Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5675-84
pubmed: 20538991
Invest Ophthalmol Vis Sci. 2010 Jan;51(1):295-307
pubmed: 19696175
Invest Ophthalmol Vis Sci. 2014 May 08;55(6):3509-16
pubmed: 24812551
Exp Eye Res. 1988 Sep;47(3):429-36
pubmed: 3181326
Curr Opin Pharmacol. 2013 Feb;13(1):36-42
pubmed: 23009741
Exp Eye Res. 2011 Aug;93(2):120-32
pubmed: 20849846
Adv Exp Med Biol. 1998;454:629-34
pubmed: 9889943
Radiat Res. 2008 Mar;169(3):350-4
pubmed: 18302491
Prog Retin Eye Res. 2000 Jan;19(1):1-40
pubmed: 10614679
Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5226-37
pubmed: 19494203
JAMA Ophthalmol. 2013 May;131(5):651-8
pubmed: 23538512
Asia Pac J Ophthalmol (Phila). 2016 Jan-Feb;5(1):38-44
pubmed: 26886118
J Biomech Eng. 2009 May;131(5):051011
pubmed: 19388781
Acta Ophthalmol. 2010 Nov;88(7):723-9
pubmed: 19725814
Invest Ophthalmol Vis Sci. 2009 Feb;50(2):681-90
pubmed: 18806292
Circ Res. 1994 Nov;75(5):904-15
pubmed: 7923637
Br J Ophthalmol. 1994 Aug;78(8):643-8
pubmed: 7918293
EPMA J. 2015 Oct 26;6:21
pubmed: 26504500
J Biomech Eng. 2012 Jan;134(1):011005
pubmed: 22482660
Optom Vis Sci. 2008 Jun;85(6):425-35
pubmed: 18521012
Invest Ophthalmol Vis Sci. 1984 Aug;25(8):918-31
pubmed: 6746235
Biomech Model Mechanobiol. 2017 Jun;16(3):871-887
pubmed: 27909833
Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4189-99
pubmed: 16249498
J Biomech. 1999 May;32(5):531-7
pubmed: 10327007
Am J Physiol Heart Circ Physiol. 2005 Dec;289(6):H2657-64
pubmed: 16040719
Arch Ophthalmol. 2012 Mar;130(3):312-8
pubmed: 22411660
Invest Ophthalmol Vis Sci. 2008 Jan;49(1):275-81
pubmed: 18172103
Ann Biomed Eng. 2010 Apr;38(4):1586-92
pubmed: 20039133
Exp Eye Res. 1995 Jul;61(1):33-44
pubmed: 7556468
Int Ophthalmol. 2018 Apr;38(2):541-547
pubmed: 28289948
JAMA. 2014 May 14;311(18):1901-11
pubmed: 24825645
Graefes Arch Clin Exp Ophthalmol. 2014 Oct;252(10):1569-71
pubmed: 24676960
Prog Retin Eye Res. 2005 Jan;24(1):39-73
pubmed: 15555526
Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4378-87
pubmed: 15557446
Prog Retin Eye Res. 1998 Apr;17(2):267-89
pubmed: 9695795
Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):154-165
pubmed: 29332130
Math Biosci. 2014 Nov;257:33-41
pubmed: 25149561
Invest Ophthalmol Vis Sci. 2016 May 1;57(6):2452-62
pubmed: 27149695
Curr Opin Pharmacol. 2013 Feb;13(1):83-9
pubmed: 22999652
Arch Ophthalmol. 2001 Dec;119(12):1810-4
pubmed: 11735792
Invest Ophthalmol Vis Sci. 2018 May 1;59(6):2564-2575
pubmed: 29847664
J Vis Exp. 2016 Dec 13;(118):
pubmed: 28060331
Invest Ophthalmol Vis Sci. 1986 Sep;27(9):1342-50
pubmed: 3744724
Arch Ophthalmol. 1992 Feb;110(2):211-3
pubmed: 1736870
Microvasc Res. 1989 Jul;38(1):81-101
pubmed: 2761434
Ann Biomed Eng. 2001 Apr;29(4):298-310
pubmed: 11339327
Invest Ophthalmol Vis Sci. 2017 Apr 1;58(4):2070-2078
pubmed: 28389675
J Formos Med Assoc. 2003 Aug;102(8):539-43
pubmed: 14569318
J Coupled Syst Multiscale Dyn. 2013 Apr 1;1(1):1-21
pubmed: 24501718
Acta Ophthalmol. 2014 Jun;92(4):e252-66
pubmed: 24238296
Prog Retin Eye Res. 2016 Nov;55:82-107
pubmed: 27417037
Invest Ophthalmol Vis Sci. 2015 Mar 03;56(3):2031-42
pubmed: 25736791
Prog Retin Eye Res. 2002 Jul;21(4):359-93
pubmed: 12150988
Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3460-6
pubmed: 11006239

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH